PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment

Wing Lam, Yung-Chi Cheng|Scientific Reports|2015

Cited by 111